Top Markets
#1 龙虾 (Lobster) 龙虾 (Lobster) +34.74%
#2 Cortex Cortex +32.63%
#3 DexNet DexNet +23.20%
#4 wojak wojak +21.48%
#5 Akedo Akedo +20.54%
#6 Pons Pons +18.91%
#7 SODAX SODAX +17.42%
#8 APEX APEX +13.93%
#9 ETHGas ETHGas +13.11%
#10 OpenEden OpenEden +12.21%
Coin of the day
龙虾 (Lobster) 龙虾 (Lobster)
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Pharma Mar, S.A. Pharma Mar, S.A.

Pharma Mar, S.A.

PHM
Hisse Senetlerindeki Sıralama #7111
Pharma Mar, S.A., a biopharmaceutical firm established in 1986 and... Pharma Mar, S.A., a biopharmaceutical firm established in 1986 and headquartered in Madrid, Spain, is dedicated to the research, development, production, and global sale of marine-derived bioactive compounds. Its primary focus is oncology, with operations spanning Spain, Italy, Germany, Ireland, the wider European Union, the United States, and other international markets. The company's activities are organized into three key segments: Oncology, Diagnostics, and RNA interference. Among its developed and commercialized treatments are Yondelis, prescribed for soft tissue sarcomas and ovarian cancer; Aplidin, targeting multiple myeloma; and Zepzelca, used for patients with small cell lung cancer. Furthermore, Pharma Mar is advancing PM14, currently in Phase II clinical trials for various solid tumors. Beyond pharmaceuticals, the company manufactures and markets diagnostic kits and is involved in creating therapeutic drugs designed to reduce or silence gene expression.
Hisse Fiyatı
$99.16
Son senkronizasyon: 2026-08-27
Piyasa Değeri
$1.72B
Değişim (1 gün)
0.00%
Değişim (1 yıl)
2.52%
Ülke
ES
Ticaret Pharma Mar, S.A. (PHM)

Kategori

Healthcare
Pharma Mar, S.A. (PHM) için gelir
Aug 2026 itibarıyla gelir TTM: 0
Pharma Mar, S.A. şirketinin en son finansal raporlarına göre, mevcut geliri (TTM) 0'dir. 2026 yılında şirketin geliri 0 önceki yıla eşit 2026 yılındaki 0 gelirine göre. Gelir, bir şirketin mal veya hizmet satışından elde ettiği toplam tutardır. Kazançtan farklı olarak, hiçbir gider düşülmez.
Pharma Mar, S.A. için 2026 ile 2026 arasındaki gelir geçmişi
Her yılın sonunda gelir
Yıl Gelir Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakiplerin geliri
Şirket Gelir Gelir Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH